Author Claim Review

 Quick Explanation Copied

 Long Explanation

Identity and attribution check

Neither supplied paper's metadata, funding statements, or author acknowledgments name Roshni Jha. The 5xFAD/JHMV preprint credits NIH T32 trainees "DIJ" and "NK" and F31 awardee "KIT" — no Jha appears in the funding or provenance fields 5xFAD JHMV preprint funding statement, and the Nature SARS-CoV-2 antibody-evolution paper is a Rockefeller-led longitudinal cohort with no Jha attribution in its provenance Nature SARS-CoV-2 antibody evolution cohort. Assigning these works' strengths to R. Jha would therefore be a name-attribution leap, not a verified inference.

What the indexed record actually shows

Bio.SemanticScholar lists 7 papers attributed to R. Jha — deep learning applications (deepfake detection, brain tumor segmentation, corn leaf disease, federated learning) — with h-index 1 and 2 total citations. OpenAlex reveals an additional problem: at least seven name-collision profiles, only one (a 2018 particle-swarm-optimization routing paper in a low-tier journal, 4 citations) with any traction. This entanglement makes author-level scoring inherently unreliable.

Interpretation: Regardless of which profile is the right person, the total evidence base is < 10 citations across ~8 works — too sparse to assess scientific strength through impact. The strongest signal is breadth-versus-depth: works span unrelated applied-ML topics with no visible methodological through-line, which typically indicates exploratory early-career output rather than a developing expertise niche. Confidence: moderate — name ambiguity across OpenAlex profiles is a documented blind spot, and any claim beyond this would require disambiguation (ORCID, full author lists) that is missing here.

 BGPT Author Review

Scientific Quality

Indexed output is 7–8 applied-ML papers with h-index 1 and ≤6 total citations; neither supplied paper is verifiably hers. Score reflects unverifiable attribution, thin impact, and lack of demonstrated depth, while acknowledging early-career status.

Communication Quality

Paper titles are clear and descriptive but formulaic; no accessible to judge communication directly from supplied records. Blank affiliations and no ORCID limit assessment.

Author Novelty

Paper titles indicate application of established architectures (ResNet, U-Net, ViT, attention) to standard benchmark problems; no methodological novelty is visible from titles or metrics.

Scientific Rigor

Cannot be rigorously assessed: no methods, sample sizes, or validations attributable to this author appear in supplied records. Default to below-midline pending evidence; absence of cited quantitative benchmarks is itself a gap.